Pharma Focus Asia

Rocket Pharmaceuticals Constructs New R & D Manufacturing Facility

Introduction:

Rocket Pharmaceuticals plans to construct a new R & D and manufacturing facility in Cranbury, New Jersey.

Features:

The new facility is designed for the development of innovative gene therapy pipeline. The facility will be constructed with an area consisting of 103,720 ft2. In addition, it will also be used to support the pivotal trialsof the increasing pipeline ofLentivirus (LV) and Adeno-Associated Virus (AAV) gene therapies.

This new world-class R & D manufacturing facilityenables new capabilities towards bringingfive curative gene therapies to rare disease patients by 2025.

State of the Art R&D facilitywill support gene therapy capabilitiesby advancing multiple platforms and programs efficiently.

The one-half of the facility will be utilised for AAV Current Good Manufacturing Practice (cGMP) production whereas the second half includes R & D labs to support increasingpipeline and Quality Control (QC) laboratoriesto support CMC development for process and analytics.

After the construction of the new facility it is expected to create 150 new employees.

Specifications:

NameRocket Pharmaceuticals
TypeNew Construction
Year2025
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024